Children & Apos;S Cancer Therapy Development Institute

Children's Cancer Therapy Development Institute, based in Beaverton, OR, is dedicated to enhancing the survival rates of children facing cancer. As of 2024, this institution has facilitated the progression of two drugs through three clinical trials aimed at treating childhood cancer. The team at cc-TDI is committed to researching effective and less toxic treatment options for pediatric cancers, addressing the disparity in drug approvals for childhood cancer compared to adult cancer.

With a strong focus on rare childhood cancers, cc-TDI collaborates with various stakeholders, including the National Institutes of Health (NIH), to delve into the genetic drivers of diseases like rhabdomyosarcoma. Their research efforts are geared towards understanding the underlying mechanisms of these cancers, paving the way for innovative therapeutic approaches. The institute's initiatives extend to exploring patient-specific testing systems and legacy programs to accelerate childhood cancer research.

Generated from the website content